top of page
Search

FMTVDM FRONTIER™ Changing the World Through Measurable Medicine

  • Writer: Richard M Fleming, PhD, MD, JD
    Richard M Fleming, PhD, MD, JD
  • Dec 22, 2025
  • 2 min read

The world does not suffer from a lack of medical technology.

It suffers from a lack of measurement.


For decades, healthcare has relied on inference, visual interpretation, relative comparisons, and population averages. We have described disease, debated disease, and reacted to disease — often after irreversible damage had already occurred.


FMTVDM FRONTIER™ changes that.


This is not a new scanner.

Not a new algorithm.

Not another AI promise.


It is a fundamental shift in how medicine understands reality.


🌍 The Global Failure Beneath Every Crisis


The greatest health crises of our time — cardiovascular disease, cancer, chronic inflammatory illness, post-viral syndromes, and escalating healthcare costs — share a single underlying flaw:


|We have not been measuring disease.

|We have been inferring it.


Visual reads vary by observer.

Relative uptake varies by equipment.

Population thresholds fail individuals.


When disease cannot be measured, it cannot be managed — only reacted to.


📏 What Measurable Medicine Means


FMTVDM FRONTIER™ introduces medicine to the same standard that governs physics, engineering, and every mature science:


| If it matters, it must be measured.


FMTVDM® (Fleming Method for Tissue and Vascular Differentiation and Metabolism) is a patented, peer-reviewed, physics-based quantitative method that transforms PET and SPECT imaging into true measurement instruments.


Not “hot spots.”

Not relative SUVs.

Not subjective impressions.


Actual, reproducible, patient-specific data.


🔬 From Interpretation to Truth


FMTVDM FRONTIER™ directly quantifies:


  • Inflammation

  • Thrombosis

  • Metabolic activity

  • Treatment response

  • Disease progression and regression


Across time.

Across platforms.

Across borders.


What was once guessed is now measured.


🧠 Why This Changes Everything


  1. Earlier Detection


Disease is identified before symptoms become irreversible damage.



  1. Objective Treatment Decisions


Therapies are continued, modified, or stopped based on measured response, not hope.



  1. Personalized Medicine That Is Real


Care is tailored to the individual patient’s biology, not population statistics.



  1. Reproducibility Restored


Results obtained in one hospital can be validated in another — anywhere in the world.



🏛️ A New Foundation for National Health


FMTVDM FRONTIER™ is not merely a clinical advance — it is a strategic national asset.


Nations that implement measurable medicine:


  • Own their diagnostic truth

  • Control their clinical data

  • Reduce dependence on opaque external standards

  • Improve outcomes while reducing waste


This is scientific sovereignty — and it matters.



🌐 Global, Not Elitist


Unlike boutique precision medicine reserved for a few, FMTVDM FRONTIER™ is:


  • Scalable

  • Trainable

  • Platform-agnostic

  • Deployable across PET and SPECT

  • Adaptable to diverse healthcare systems


Measurable medicine is not a luxury.

It is a necessity.



🚀 Changing the World, One Measurement at a Time


When disease is measurable:


  • Prevention becomes actionable

  • Treatment becomes accountable

  • Outcomes become undeniable


FMTVDM FRONTIER™ does not promise perfection.

It delivers clarity.


And clarity changes everything.



✨ The Measurable Era Has Begun


Every great transformation begins when a field accepts a hard truth.


Medicine’s hard truth is this:


| You cannot heal what you do not measure.


FMTVDM FRONTIER™ marks the crossing of the Gold Horizon Line — the moment medicine steps out of inference and into evidence.


The world does not need more opinion.

It needs measurement.


And measurement has arrived.



FMTVDM FRONTIER™ introduces measurable medicine by transforming PET and SPECT imaging into quantitative tools that objectively measure inflammation, metabolism, disease progression, and treatment response across populations and nations.
FMTVDM FRONTIER™ introduces measurable medicine by transforming PET and SPECT imaging into quantitative tools that objectively measure inflammation, metabolism, disease progression, and treatment response across populations and nations.



 
 
 

Comments


IMG_1843_edited.png

EMAIL FMTVDM FRONTIER
CONSORTIUM
DIRECTLY

IMG_1927.gif
ai2.png

FMTVDM FRONTIER INQUIRY

Multi-line address
Drawing mode selected. Drawing requires a mouse or touchpad. For keyboard accessibility, select Type or Upload.

© 2025 by Richard M Fleming, PhD, MD, JD.

Director, FMTVDM FRONTIER Consortium

Powered and secured by Wix

bottom of page